Cancer, Autoantigens, and Scleroderma Investigating the Connection

癌症、自身抗原和硬皮病之间的联系研究

• 批准号: 8699677
• 负责人: Ami Aalok Shah
• 金额: $ 13.68万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-08-01 至 2017-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8699677
• 关键词: Adenocarcinoma; Age; Antibodies; Antigens; Autoantibodies; Autoantigens; Autoimmune Diseases; Award; Biometry; Blood Vessels; Cancer Control; Cancer Histology; Cancer Patient; Cancerous; Characteristics; Clinical; Clinical Research; Clinical Trials; Collaborations; Complex; Conflict (Psychology); Data; Data Aggregation; Databases; Dermatomyositis; Development; Diffuse Scleroderma; Disease; Environment; Epidemiologic Studies; Epidemiology; Event; Fibrosis; Foundations; Gender; General Population; Goals; High-Risk Cancer; Hospitals; Immune response; Immunoblotting; Immunohistochemistry; Immunologics; Investigation; Kidney; Laboratories; Link; Longitudinal Studies; Malignant Neoplasms; Mentored Patient-Oriented Research Career Development Award; Mentors; Mentorship; Methods; Modeling; Molecular; Muscle; Myoblasts; Myositis; NPM1 gene; Natural regeneration; Nerve Degeneration; Outcome; Paraneoplastic Syndromes; Pathogenesis; Patients; Pattern; Phenotype; Population; Public Health Schools; RNA Polymerase III; Relative (related person); Reporting; Research; Research Personnel; Resources; Rheumatism; Rheumatology; Risk; Risk Factors; Sampling; Scleroderma; Screening for cancer; Serological; Serum; Skin; Smoking; Source; Specific qualifier value; Specificity; Specimen; Syndrome; Systemic Scleroderma; Therapeutic immunosuppression; Thick; Time; Tissues; Training; Training Programs; Translational Research; Type I DNA Topoisomerases; Validation; Work; cancer diagnosis; cancer risk; cancer therapy; career; centromere autoantigen 80K; clinically relevant; cohort; data management; epidemiology study; illness length; insight; novel; oncology; patient population; programs; prospective; public health relevance; response; screening; skills; success; treatment response; tumor

DESCRIPTION (provided by applicant): The major goal of this proposal is to attain clinical and translational research skills to become an excellent, independent investigator in rheumatology, with a focus in scleroderma. Systemic sclerosis (scleroderma) is a complex, multisystem disease involving tissue fibrosis, immunological derangements and vascular abnormalities. Previous epidemiological studies provide compelling evidence that patients with scleroderma have an increased risk of cancer compared to the general population. Observations of a close temporal relationship between cancer diagnosis and scleroderma onset, and reports of cancer therapy halting scleroderma progression, suggest that scleroderma may be a paraneoplastic syndrome in some patients. In this proposal, the candidate will probe the temporal relationship between scleroderma and cancer, examine risk factors for cancer in scleroderma, and assess whether scleroderma autoantigen expression in tumors is associated with the immune response. This research will define patient subsets that may benefit from targeted malignancy screening, provide insight into mechanisms relevant in scleroderma pathogenesis, and offer the candidate an opportunity to build a strong clinical and translational research program in a mentored environment. The candidate has demonstrated a commitment to a career in academic rheumatology through her training in Johns Hopkins' Graduate Training Program in Clinical Investigation and her ability to initiate and complete investigations of clinically relevant questins in scleroderma. This Mentored Patient-Oriented Research Career Development Award will afford the candidate the opportunity to continue building on these skills, in part through planned coursework at the Johns Hopkins Bloomberg School of Public Health. The dedicated mentorship team, diverse clinical and research environment in the Division of Rheumatology, and resources of the School of Public Health are an ideal foundation for this mentored patient-oriented research career development award. The large team of mentors and collaborators for this proposal provide significant expertise in studying the epidemiology and basic immunologic underpinnings of scleroderma and cancer. In addition, the resources of the Johns Hopkins Scleroderma Center (JHSC); the large JHSC and Royal Free Hospital scleroderma databases of over 4800 subjects; the Bayview Biostatistics, Epidemiology and Data Management (BEAD) Core; the Johns Hopkins Division of Oncology; and the Rheumatic Diseases Research Core Center (RDRCC) are fully available to make this project a success.

描述（由申请人提供）：本提案的主要目标是获得临床和转化研究技能，成为风湿病领域优秀的独立研究者，重点关注硬皮病。系统性硬化症（硬皮病）是一种复杂的多系统疾病，涉及组织纤维化、免疫紊乱和血管异常。先前的流行病学研究提供了令人信服的证据，表明硬皮病患者与普通人群相比，患癌症的风险更高。对癌症诊断和硬皮病发病之间密切时间关系的观察，以及癌症治疗阻止硬皮病进展的报告表明，硬皮病可能是某些患者的副肿瘤综合征。在该提案中，候选人将探讨硬皮病和癌症之间的时间关系，检查硬皮病中癌症的危险因素，并评估肿瘤中硬皮病自身抗原的表达是否与免疫反应相关。这项研究将定义可能受益于针对性恶性肿瘤筛查的患者子集，深入了解硬皮病发病机制的相关机制，并为候选人提供在指导环境中建立强大的临床和转化研究项目的机会。通过接受约翰·霍普金斯大学临床研究研究生培训计划的培训，以及她启动和完成硬皮病临床相关问题研究的能力，该候选人表现出了对学术风湿病学职业生涯的承诺。这项以患者为导向的研究职业发展奖将为候选人提供继续发展这些技能的机会，部分是通过约翰霍普金斯大学彭博公共卫生学院计划的课程学习。风湿科专业的导师团队、多元化的临床和研究环境以及公共卫生学院的资源是这一以患者为导向的研究职业发展奖的理想基础。该提案的导师和合作者组成的庞大团队在研究硬皮病和癌症的流行病学和基本免疫学基础方面提供了重要的专业知识。此外，约翰·霍普金斯硬皮病中心 (JHSC) 的资源； JHSC 和皇家自由医院硬皮病大型数据库，包含超过 4800 名受试者； Bayview 生物统计学、流行病学和数据管理 (BEAD) 核心；约翰·霍普金斯大学肿瘤科；风湿病研究核心中心 (RDRCC) 完全可以帮助该项目取得成功。